Tenet Healthcare (NYSE:THC) Sets New 12-Month High – Here’s Why

Shares of Tenet Healthcare Corporation (NYSE:THC) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $262.70 and last traded at $262.7870, with a volume of 508079 shares changing hands. The stock had previously closed at $253.33.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on THC. Morgan Stanley increased their target price on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. Stephens restated an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a research note on Monday, July 27th. Raymond James Financial set a $270.00 target price on Tenet Healthcare in a research report on Monday, July 27th. Piper Sandler set a $308.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, Barclays upped their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday, July 24th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $271.00.

Tenet Healthcare Stock Performance

The stock’s 50 day moving average price is $195.15 and its 200 day moving average price is $200.11. The company has a market capitalization of $22.54 billion, a P/E ratio of 10.10, a price-to-earnings-growth ratio of 0.95 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. During the same quarter in the prior year, the firm posted $4.02 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts expect that Tenet Healthcare Corporation will post 21.09 EPS for the current year.

Insider Activity at Tenet Healthcare

In other news, EVP Lisa Y. Foo sold 10,000 shares of the company’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the transaction, the executive vice president owned 32,053 shares in the company, valued at approximately $8,270,635.59. This represents a 23.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. This trade represents a 25.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 33,353 shares of company stock worth $7,683,517. Corporate insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the company. Swedbank AB increased its stake in Tenet Healthcare by 14.7% during the 4th quarter. Swedbank AB now owns 146,133 shares of the company’s stock valued at $29,040,000 after purchasing an additional 18,750 shares in the last quarter. Jackson Creek Investment Advisors LLC grew its holdings in shares of Tenet Healthcare by 235.6% during the fourth quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock valued at $1,795,000 after buying an additional 6,341 shares during the last quarter. Hsbc Holdings PLC raised its holdings in shares of Tenet Healthcare by 3,478.7% in the 4th quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after acquiring an additional 258,956 shares during the last quarter. Louisiana State Employees Retirement System bought a new position in Tenet Healthcare in the 1st quarter valued at about $4,812,000. Finally, Brandywine Global Investment Management LLC increased its holdings in Tenet Healthcare by 20.5% during the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock worth $25,088,000 after purchasing an additional 21,435 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.